{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:54:06Z","timestamp":1792601646525,"version":"4.5.0"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR 24520\/MED\/29\/1222\/2017"],"award-info":[{"award-number":["BT\/PR 24520\/MED\/29\/1222\/2017"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2021\/003984"],"award-info":[{"award-number":["CRG\/2021\/003984"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>A limited subset of HIV-1 infected adult individuals typically after at least 2-3 years of chronic infection, develop broadly neutralizing antibodies (bnAbs), suggesting that highly conserved neutralizing epitopes on the HIV-1 envelope glycoprotein are difficult for B cell receptors to effectively target, during natural infection. Recent studies have shown the evolution of bnAbs in HIV-1 infected infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We used bulk BCR sequencing (BCR-seq) to profile the B cell receptors from longitudinal samples (3 time points) collected from a rare pair of antiretroviralna\u00efve, HIV-1 infected pediatric monozygotic twins (AIIMS_329 and AIIMS_330) who displayed elite plasma neutralizing activity against HIV-1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>BCR-seq of both twins revealed convergent antibody characteristics including V-gene use, CDRH3 lengths and somatic hypermutation (SHM). Further, antibody clonotypes with genetic features similar to highly potent bnAbs isolated from adults showed ongoing development in donor AIIMS_330 but not in AIIMS_329, corroborating our earlier findings based on plasma bnAbs responses. An increase in SHM was observed in sequences of the IgA isotype from AIIMS_330.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study suggests that children living with chronic HIV-1 can develop clonotypes of HIV-1 bnAbs against multiple envelope epitopes similar to those isolated from adults, highlighting that such B cells could be steered to elicit bnAbs responses through vaccines aimed to induce bnAbs against HIV-1 in a broad range of people including children.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2024.1272493","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T02:57:46Z","timestamp":1708052266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["B cell repertoire sequencing of HIV-1 pediatric elite-neutralizers identifies multiple broadly neutralizing antibody clonotypes"],"prefix":"10.3389","volume":"15","author":[{"given":"Sanjeev","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Collin","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Kumar","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Briney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"B1","unstructured":"UNAIDS data 2022"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002251","article-title":"Extremely high mutation rate of HIV-1 in vivo","volume":"13","author":"Cuevas","year":"2015","journal-title":"PloS Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2020.03.014","article-title":"The biology of the HIV-1 latent reservoir and implications for cure strategies","volume":"27","author":"Cohn","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.24.021605.090557","article-title":"GP120: target for neutralizing HIV-1 antibodies","volume":"24","author":"Pantophlet","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-018-0235-7","article-title":"Recent progress in broadly neutralizing antibodies to HIV","volume":"19","author":"Sok","year":"2018","journal-title":"Nat Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c07933","article-title":"An overview of human anti-HIV-1 neutralizing antibodies against diverse epitopes of HIV-1","volume":"8","author":"Kumar","year":"2023","journal-title":"ACS Omega"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-041015-055515","article-title":"Broadly neutralizing antibodies to HIV and their role in vaccine design","volume":"20","author":"Burton","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-022-00446-4","article-title":"High thermostability improves neutralizing antibody responses induced by native-like HIV-1 envelope trimers","volume":"7","author":"del Moral-S\u00e1nchez","year":"2022","journal-title":"NPJ Vaccines"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003618","article-title":"A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies","volume":"9","author":"Sanders","year":"2013","journal-title":"PloS Pathog"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.27.554987v1","article-title":"Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines","author":"del Moral-S\u00e1nchez","year":"2023","journal-title":"bioRxiv"},{"key":"B11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.cell.2016.05.055","article-title":"HIV-1 neutralizing antibodies with limited hypermutation from an infant","volume":"166","author":"Simonich","year":"2016","journal-title":"Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01495-18","article-title":"An HIV-1 broadly neutralizing antibody from a clade C-infected pediatric elite neutralizer potently neutralizes the contemporaneous and autologous evolving viruses","volume":"93","author":"Kumar","year":"2019","journal-title":"J Virol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3565","article-title":"Early development of broadly neutralizing antibodies in HIV-1-infected infants","volume":"20","author":"Goo","year":"2014","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001480","article-title":"Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children","volume":"101","author":"Kumar","year":"2020","journal-title":"J Gen Virol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1038\/s41467-020-18225-x","article-title":"Broadly neutralizing plasma antibodies effective against autologous circulating viruses in infants with multivariant HIV-1 infection","volume":"11","author":"Mishra","year":"2020","journal-title":"Nat Commun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00814-20","article-title":"A rare mutation in an infant-derived HIV-1 envelope glycoprotein alters interprotomer stability and susceptibility to broadly neutralizing antibodies targeting the trimer apex","volume":"94","author":"Mishra","year":"2020","journal-title":"J Virol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01697","article-title":"Alterations in B cell compartment correlate with poor neutralization response and disease progression in HIV-1 infected children","volume":"8","author":"Aggarwal","year":"2017","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000824","article-title":"Evolution of cross-neutralizing antibodies and mapping epitope specificity in plasma of chronic HIV-1-infected antiretroviral therapy-na\u00efve children from India","volume":"98","author":"Makhdoomi","year":"2017","journal-title":"J Gen Virol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1128\/JVI.00878-18","article-title":"HIV-1 subtype C infected children with exceptional neutralization breadth exhibit polyclonal responses targeting known epitopes","volume":"92","author":"Ditse","year":"2018","journal-title":"J Virol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"358ra125","DOI":"10.1126\/scitranslmed.aag1048","article-title":"Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection","volume":"8","author":"Muenchhoff","year":"2016","journal-title":"Sci Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00391","article-title":"Immunity to HIV in early life","volume":"5","author":"Muenchhoff","year":"2014","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00654-19","article-title":"Viral characteristics associated with maintenance of elite neutralizing activity in chronically HIV-1 clade C infected monozygotic pediatric twins","volume":"93","author":"Mishra","year":"2019","journal-title":"J Virol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0125575","article-title":"Identification of CD4-binding site dependent plasma neutralizing antibodies in an HIV-1 infected Indian individual","volume":"10","author":"Khan","year":"2015","journal-title":"PloS One"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01568","article-title":"CD4-binding site directed cross-neutralizing scFv monoclonals from HIV-1 subtype C infected Indian children","volume":"8","author":"Kumar","year":"2017","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"45163","DOI":"10.1038\/srep45163","article-title":"Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library","volume":"7","author":"Khan","year":"2017","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-S3-E25","article-title":"Production of cross neutralizing single chain fragment variables (scFv) from HIV-1 infected Indian children","volume":"14","author":"Kumar","year":"2014","journal-title":"BMC Infect Dis"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0879-y","article-title":"Commonality despite exceptional diversity in the baseline human antibody repertoire","volume":"566","author":"Briney","year":"2019","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btv359","article-title":"Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data","volume":"31","author":"Gupta","year":"2015","journal-title":"Bioinformatics"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu138","article-title":"pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires","volume":"30","author":"Vander Heiden","year":"2014","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv404","article-title":"CATNAP: a tool to compile, analyze and tally neutralizing antibody panels","volume":"43","author":"Yoon","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2020.524413","article-title":"The usage of human IGHJ genes follows a particular non-random selection: the recombination signal sequence may affect the usage of human IGHJ genes","volume":"11","author":"Shi","year":"2020","journal-title":"Front Genet"},{"key":"B32","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.immuni.2017.04.011","article-title":"Virus-like particles identify an HIV V1V2 apex-binding neutralizing antibody that lacks a protruding loop","volume":"46","author":"Cale","year":"2017","journal-title":"Immunity"},{"key":"B33","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.chom.2020.01.027","article-title":"VRC34-antibody lineage development reveals how a required rare mutation shapes the maturation of a broad HIV-neutralizing lineage","volume":"27","author":"Shen","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018207","article-title":"An anti-HIV-1 V3 loop antibody fully protects cross-clade and elicits T-cell immunity in macaques mucosally challenged with an R5 clade C SHIV","volume":"6","author":"Watkins","year":"2011","journal-title":"PloS One"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001195","article-title":"Crystal structure and size-dependent neutralization properties of HK20, a human monoclonal antibody binding to the highly conserved heptad repeat 1 of gp41","volume":"6","author":"Sabin","year":"2010","journal-title":"PloS Pathog"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aai7514","article-title":"Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies","volume":"9","author":"Bonsignori","year":"2017","journal-title":"Sci Transl Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"100314","DOI":"10.1016\/j.xcrm.2021.100314","article-title":"A diverse collection of B cells responded to HIV infection in infant BG505","volume":"2","author":"Simonich","year":"2021","journal-title":"Cell Rep Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.022","article-title":"Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody","volume":"165","author":"Bonsignori","year":"2016","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2012.12.010","article-title":"Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals","volume":"439","author":"Andrabi","year":"2013","journal-title":"Virology"},{"key":"B40","doi-asserted-by":"publisher","first-page":"109922","DOI":"10.1016\/j.celrep.2021.109922","article-title":"Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies","volume":"37","author":"Cottrell","year":"2021","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aal2200","article-title":"Potent and broad HIV-neutralizing antibodies in memory B cells and plasma","volume":"2","author":"Williams","year":"2017","journal-title":"Sci Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2018.04.025","article-title":"Strategies for a multi-stage neutralizing antibody-based HIV vaccine","volume":"53","author":"Andrabi","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030262","article-title":"What are the most powerful immunogen design vaccine strategies? Reverse vaccinology 2.0 shows great promise","volume":"9","author":"Burton","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"107579","DOI":"10.1016\/j.isci.2023.107579","article-title":"Recognition determinants of improved HIV-1 neutralization by a heavy chain matured pediatric antibody","volume":"26","author":"Kumar","year":"","journal-title":"iScience"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180245","article-title":"Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy","volume":"12","author":"Nabi","year":"2017","journal-title":"PloS One"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1101\/2021.11.26.470157","article-title":"A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2","volume":"55","author":"Wang","year":"2022","journal-title":"Immunity"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52384.sa2","article-title":"Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics","volume":"8","author":"Durham","year":"2019","journal-title":"Elife"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1272493\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T02:57:54Z","timestamp":1708052274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1272493\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":47,"alternative-id":["10.3389\/fimmu.2024.1272493"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1272493","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.07.07.548149","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]},"article-number":"1272493"}}